Our nowcast pegged growth in 2Q21 at +18.4% y/y, but a subsequent moderation in growth looms large. As the inoculation drive gains momentum, a strong finish to the year appears increasingly likely.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.